Long-term sterilizing immunity to rinderpest in cattle vaccinated with a recombinant vaccinia virus expressing high levels of the fusion and hemagglutinin glycoproteins

Journal of Virology

Volumn 76, Issue 2, 2002, Pages 484-491

  Verardi, P H ^a   Aziz, F H ^a   Ahmad, S ^a   Jones, L A ^a   Beyene, B ^a   Ngotho, R N ^a   Wamwayi, H M ^a   Yesus, M G ^a   Egziabher, B G ^a   Yilma, T D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN; VIRUS HEMAGGLUTININ; VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CATTLE DISEASE; CATTLE PLAGUE VIRUS; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; GENE EXPRESSION; IMMUNITY; LETHAL DOSE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SEROLOGY; SYNCYTIUM; VACCINATION; VACCINIA VIRUS; VIRUS RECOMBINANT; VIRUS TRANSMISSION;

ANIMALS; CATTLE; CATTLE DISEASES; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; GIANT CELLS; HEMAGGLUTININS, VIRAL; INJECTIONS, INTRAMUSCULAR; MORBILLIVIRUS; NEUTRALIZATION TESTS; PRECIPITIN TESTS; RECOMBINANT FUSION PROTEINS; RINDERPEST; SURVIVAL RATE; TIME FACTORS; VACCINATION; VACCINES, SYNTHETIC; VACCINIA VIRUS; VERO CELLS; VIRAL PROTEINS; VIRAL VACCINES;

EID: 0036138040     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.2.484-491.2002     Document Type: Article

References (43)

1. Rediscovery of the second African lineage of rinderpest virus: Its epidemiological significance
2. Rinderpest: The disease and its impact on humans and animals
3. Immunological responses of mice and cattle to baculovirus-expressed F and H proteins of rinderpest virus: Lack of protection in the presence of neutralizing antibody
4. Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype
5. Vaccinia virus expression vector: Coexpression of β-galactosidase provides visual screening of recombinant virus plaques
6. Compact, synthetic, vaccinia virus early/late promoter for protein expression
7. Generation of recombinant vaccinia viruses
8. A vaccinia virus double recombinant expressing the F and H genes of rinderpest virus protects cattle against rinderpest and causes no pock lesions
9. Vaccinia virus recombinants expressing chimeric proteins of human immunodeficiency virus and γ interferon are attenuated for nude mice
10. Disturbances in gamma globulin synthesis as "experiments of nature."
11. Analysis of the polypeptides synthesized in rinderpest virus-infected cells
12. Cloning of the fusion gene of rinderpest virus: Comparative sequence analysis with other morbilliviruses
13. Long-term immunity in cattle vaccinated with a recombinant rinderpest vaccine
14. Cloning and expression of the nucleocapsid gene of virulent Kabete O strain of rinderpest virus in baculovirus: Use in differential diagnosis between vaccinated and infected animals
15. Expression of rabies virus glycoprotein from a recombinant vaccinia virus
16. Rinderpest epidemic in wild ruminants in Kenya, 1993-97
17. A rapid method for screening vaccinia virus recombinants
18. Vaccination of wildlife against rabies: Successful use of a vectored vaccine obtained by recombinant technology
19. Production of a thermostable Vero cell-adapted rinderpest vaccine
20. Comparison of the effect of various chemical stabilizers and lyophilization cycles on the thermostability of a Vero cell-adapted rinderpest vaccine
21. Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety
22. Trial of a capripoxvirus-rinderpest recombinant vaccine in African cattle
23. Functional and structural interactions between measles virus hemagglutinin and CD46
24. Long-term protective immunity to rinderpest in cattle following a single vaccination with a recombinant vaccinia virus expressing the virus haemagglutinin protein
25. The development and use of a vaccinia-rabies recombinant oral vaccine for the control of wildlife rabies: A link between Jenner and Pasteur
26. Epidemiology and control of fox rabies in Europe
27. The duration of immunity in cattle following inoculation of rinderpest cell culture vaccine
28. Rinderpest virus
29. Studies with rinderpest virus in tissue culture: The use of attenuated culture virus as a vaccine for cattle
30. Microtitre techniques for the assay of rinderpest virus and neutralising antibody
31. Subacute sclerosing panencephalitis is typically characterized by alterations in the fusion protein cytoplasmic domain of the persisting measles virus
32. A recombinant vector derived from the host range-restricted and highly attenuated MVA strain of vaccinia virus stimulates protective immunity in mice to influenza virus
33. Vaccinia virus recombinants expressing either the measles virus fusion or hemagglutinin glycoprotein protect dogs against canine distemper virus challenge
34. Protection against lethal measles virus infection in mice by immune-stimulating complexes containing the hemagglutinin or fusion protein
35. Vaccinia virus vectors with an inactivated gamma interferon receptor homolog gene (B8R) are attenuated in vivo without a concomitant reduction in immunogenicity
36. Microtitre technique for detection and titration of rinderpest virus in infected bovine tissues and secretions
37. Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene
38. Measles virus: Both the haemagglutinin and fusion glycoproteins are required for fusion
39. Expression of an adjuvant gene (interferon-γ) in infectious vaccinia virus recombinants
40. Protection of cattle against rinderpest with vaccinia virus recombinants expressing the HA or F gene
41. Evaluation of recombinant vaccinia virusmeasles vaccines in infant rhesus macaques with preexisting measles antibody